Lightnews — Scholar-powered news

Edgar V. Lerma 🇵🇭

@edgarvlermamd.bsky.social

1.5K followers 47 following 450 posts

Chicago Sports Fan... Nephrologist by day. My tweets are not medical advice. The views expressed here are my own and not those of my employer

Posts Media Videos Starter Packs

Pinned

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · Dec 4

Renal Physiology for the Clinician Series
#Nephpearls

👉 journals.lww.com/cjasn/pages/...

2 19 53

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 9h

Which patients should be on SGLT2 inhibitors (SGLT2i) ⁉️

✅ Check out the SGLT2i Cold 🥶 Map from @theisn.org
#RKDSummit #Nephpearls #NephSky

👉🏼 www.theisn.org/initiatives/...

1 4

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 10h

Interrelation of mechanistic drivers in early through advanced stages of kidney damage and disease progression in diabetes ca. 2022
#RKDSummit #Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/35661785/

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 10h

High unmet treatment needs in patients w/ CKD & type 2 diabetes (T2D): RWE from a US claims database ca. 2023
#RKDSummit #Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/35389468/

📌 Low initiation rates of SOC (ACEi/ ARB) overall & SGLT2i

📌 There were high discontinuation rates for all treatments

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 10h

Theoretical framework for the implementation of GDMT in Type 2 Diabetes (T2D) and CKD ca. 2024
#RKDSummit #Nephpearls #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/38620082/

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 11h

Barriers to appropriate medication prescribing and use in CKD ca. 2024
#RKDSummit #Nephpearls #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/39815796/

1 3

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 11h

Stages of cardiovascular-kidney-metabolic (CKM) syndrome
#RKDSummit #Nephpearls #Cardiorenal #NephSky

👉 pubmed.ncbi.nlm.nih.gov/37807924/

1 1

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 11h

Kidney Failure Events, Cardiovascular Disease Events, and All-Cause Mortality in Patients with IgA Nephropathy #IgAN in a Real-World Database ca. 2024 from @asnpublications.bsky.social
#RKDSummit #Nephpearls #NephSky

👉🏼 pubmed.ncbi.nlm.nih.gov/38323871/

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 20h

Building a Unified Future: The @asnkidney.bsky.social @asnpublications.bsky.social Journal Portfolio 2 Years In from the October 2025 issue of Kidney News
#NephSky

www.kidneynews.org/view/journal...

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 22h

I just donated to the @nephjc.bsky.social Fall 🍂 Drive

Looking forward to learning more #Nephpearls

#NephSky

👉 www.nephjc.com

1 3

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 22h

With a bit of bias towards #NephTwitter, I think 2018-2019

👉 ajkdblog.org/2022/04/20/n...

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 2d

Kidney Translation Podcasts 🎙️ from @asnkidney.bsky.social @asnpublications.bsky.social @nephrosparks.bsky.social
#Nephpearls #NephSky

👉🏼 journals.lww.com/asnjournals/...

1 2

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 4d

IgA Nephropathy #IgAN: An Overview of the Clinical Trials ca. 2025 from @kidneymed.bsky.social @alexgr23.bsky.social @saynanorouzi.bsky.social
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/41050133/

3 2

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 11d

Decision support for PICC Line placement in patients with CKD ca. 2023
#Nephpearls #VascularAccessPearls #NephSky

#VisualGraphic by @brianrifkin.bsky.social

👉🏼 pubmed.ncbi.nlm.nih.gov/34218708/

1 3 4

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 11d

Acute Hypercalcemia: Treatment
#Nephpearls #NephSky

👉🏼 shop.lww.com/Handbook-of-...

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 16d

Check out GlomPedia: The essential guide to glomerular diseases at your fingertips
#GlomConHawaii 🌊 #Nephpearls #NephSky

📌 #GlomPedia is your 🆓 go-to eBook library for glomerular diseases

Apple App Store apps.apple.com/us/app/glomp...

Google Play play.google.com/store/apps/d...

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 17d

Opinion-based approach to genetic 🧬 testing in adult-onset FSGS
#GlomConHawaii 🌊 #Nephpearls #NephSky

📌 Note that viral- and drug-associated forms of FSGS are usually excluded by clinical and serologic evaluation

👉 pubmed.ncbi.nlm.nih.gov/29321142/

2 2

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 17d

The one and only @kidneyboy.bsky.social representing #NephJC at #GlomConHawaii 🌊
#NephSky

2 6

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 17d

Updated review of membranous nephropathy: Target 🎯 antigens ca. 2024
#Nephpearls

👉 pubmed.ncbi.nlm.nih.gov/38681023/

1 2

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 17d

NefXtend: Looking at efficacy and safety of extended Nefecon treatment in adult participants who have completed 9 months of Nefecon 16 mg daily treatment
#GlomConHawaii 🌊 #Nephpearls

1 2

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 17d

Pillars of #IgAN Treatment
#GlomConHawaii 🌊 #Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/38398259/

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 17d

Its generic name "budesonide" does not distinguish targeted release formulation (TRF) of budesonide from other formulations (nasal spays, inhalers, etc.) so the name "Nefecon" was used to refer to it in the @kdigo.org guidelines for IgA Nephropathy #IgAN
#GlomConHawaii 🌊 #Nephpearls #NephSky

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 18d

Clinical Endpoints for Glomerular Diseases from
@hjanders.bsky.social
#GlomConHawaii 🌊 #Nephpearls #NephSky

2 7

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 20d

a picture of a spider man with the words didn 't think so below him

ALT: a picture of a spider man with the words didn 't think so below him

media.tenor.com

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 21d

Kidney Health Guidance on Potassium and Phosphorus Food Additives ca. 2025 from @asnpublications.bsky.social
#Nephpearls #NephSky

👉 pubmed.ncbi.nlm.nih.gov/40965988/

3 5

Edgar V. Lerma 🇵🇭 @edgarvlermamd.bsky.social · 23d

Phase 3 clinical trials open in 2025 evaluating new treatments for IgA Nephropathy #IgAN from @kdigo.org
#Nephpearls #NephSky

👉🏼 kdigo.org/guidelines/i...

1 5